RxDoctor Payments Data

Esther Vorovich, MD

Advanced Heart Failure and Transplant Cardiology · Chicago, ILNPI 1235358599

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Abiomed at 59.6% of the total. Among advanced heart failure and transplant cardiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$224,384in general payments, 2019–2025

Across 242 payments — averaging $927.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$134K
  • Abbott$36K
  • Novo Nordisk$27K
  • Novo Nordisk AS$24K
  • Amgen$4K
  • Medtronic$70
  • plus $190 from 5 others
$10,410in research payments, 2019–2025

Across 2 payments — averaging $5205.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$10K
  • Medtronic$200

What the payments were for

  • Consulting fees$68,32130%
  • Speaking & faculty fees$117,67552%
  • Travel & lodging$29,96613%
  • Food & beverage$8,4224%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$224,384 in reported general payments places this provider in the 95th percentile of 56 advanced heart failure and transplant cardiology providers in Illinois.

See all advanced heart failure and transplant cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$162,950
Medicare patients
283
Services billed
1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis32$754,726
EntrestoSacubitril/Valsartan397$464,306
JardianceEmpagliflozin199$281,654
EliquisApixaban128$153,790
FarxigaDapagliflozin Propanediol76$88,286
XareltoRivaroxaban22$36,611
Sirolimus35$13,715
Repatha SyringeEvolocumab12$10,020
Bumetanide193$9,001
Tacrolimus39$7,475
Praluent PenAlirocumab14$6,881
Eplerenone92$4,710
Metoprolol Succinate244$4,363
Spironolactone293$2,891
Rosuvastatin Calcium128$2,771

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →